http://secfilings.com/searchresultswide.aspx?link=

New Post Public Reply Private Reply Replies (0) Message Board
vegasandre
278
http://secfilings.com/searchresultswide.aspx?...d=11811133


this one is different:

Explanation of Responses:
( 1) On January 27, 2017, upon approval of the Company?s board of directors, George J. Coates and the Company mutually agreed to rescind three transactions during the year ended December 31, 2016, pursuant to which an aggregate of $314,751.62 of accrued interest on 17% promissory notes due to Mr. Coates were converted into common stock at an average price per share of $0.0008764. The effective date of the rescission was December 31, 2016. As a result of these rescissions, an aggregate of 359,139,789 shares of common stock held by Mr. Coates were canceled and restored to authorized, unissued stock and $314,751.62 of accrued interest was reinstated as a currently liability on the books of the Company as of December 31, 2016.
( 2) The average price per share of common stock rescinded was $0.0008764.
( 3) In connection with the rescission of the conversion of accrued interest due to Mr. Coates, 359,139,789 shares of common stock and 2,541,086 shares of Series B Convertible Preferred Stock held by George J. Coates were canceled. In order to maintain his percentage of all eligible votes on matters brought for a vote to the common stock shareholders at 85.76%, 670,219 shares of Series A Preferred Stock were issued to Mr. Coates on January 27, 2017. Each share of Series A Preferred Stock entitles the holder to 10,000 eligible votes.
( 4) The cancellation of 359,139,789 shares of common stock held by Mr. Coates as a result of the rescission of the conversion of accrued interest due to Mr. Coates, reduces his percentage ownership of common stock outstanding. As a result, it is also necessary to cancel 2,541,086 shares of Series B Convertible Preferred Stock held by Mr. Coates in order to properly adjust his anti-dilution shares, based on his adjusted, reduced common stock ownership percentage. The cancellation of these 2,541,086 shares of Series B Convertible Preferred Stock is being reported on six rows under this Table II in order to present all the details. This note is provided to properly explain the nature of this transaction and, accordingly, is applicable to all six rows presented.
( 5) There is no expiration date.
( 6) There is no expiration date.
( 7) There is no expiration date.
( 8) There is no expiration date.
( 9) There is no expiration date.
( 10) There is no expiration date.

Coates International (COTE) Stock Research Links

COTE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

NVIDIA Launches Quantum Research Center to Transform Computing

Updated Category News Views 205

NVIDIA Establishes a Quantum Research Center for Innovation NVIDIA has taken a significant step towards the future of technology by announcing the development of a cutting-edge research center focused on quantum computing. Introducing the NVIDIA Accelerated Quantum Research Center The newly formed NVIDIA Accelerated Quantum Research Center, or NVAQC, is strategically...

Continue Reading
Discover the New GloFish® Electric Green® Angelfish Today!

Updated Category News Views 459

Introducing the GloFish® Electric Green® Angelfish Spectrum Brands, Inc. has exciting news for aquarium enthusiasts! They have unveiled the latest addition to their vibrant family of GloFish® fluorescent fish: the GloFish® Electric Green® Angelfish. This beautiful new color adds to the popularity of the GloFish® collection, following the successful release of the...

Continue Reading
Affimed's CEO to Feature at Upcoming Healthcare Conference

Updated Category News Views 127

Affimed CEO to Participate in Global Healthcare Conference Affimed N.V. (NASDAQ: AFMD), a clinical-stage immuno-oncology company, is excited to announce that its Chief Executive Officer, Dr. Shawn Leland, will be engaging in a fireside chat at a noteworthy healthcare conference. This event, which promises to highlight advancements in the healthcare sector, is set for a...

Continue Reading
Masimo Reveals Preliminary 2024 Financial Results and Plans

Updated Category News Views 282

Masimo Corporation's Preliminary Financial Results for 2024 Masimo Corporation (NASDAQ: MASI) has recently unveiled its select preliminary financial results for the fourth quarter and full-year ending December 28, 2024, along with its initial guidance for the fiscal year 2025. The company’s commitment to enhancing patient outcomes and the cost of care continues to...

Continue Reading
Tile Shop Prepares for Upcoming Earnings Call in November

Updated Category News Views 75

Tile Shop Earnings Call Scheduled for November Tile Shop Holdings, Inc. (TTSH), a leading specialty retailer in the tile industry, has announced its plans to release its financial results for the third quarter in early November. The announcement marks an essential update for investors and stakeholders who are keen on the company’s financial performance. Details of the...

Continue Reading